Patent ID: 6448039
Filing Date: 2002-09-10
Classification: C07K,C12N

Abstract:
An isolated nucleic acid sequence selected from the group consisting of: region A having SEQ ID NO:2; binding site C having SEQ ID NO:3 GATGAGAGAGCAGT; Region C having SEQ ID NO:4 GAGCTCACTCTAGATGAGAGAGCAGTGAGGGAGAGACAGAGACTCGAATTT; and region E having SEQ ID NO:5 TTTGTGCAATTTCACTTATGATACC, wherein said nucleic acid sequence, when operably linked to a minimal promoter and a heterologous nucleic acid molecule to form an expression cassette, induces expression of said heterologous nucleic acid molecule when the expression cassette is transfected into a peripheral blood lymphocyte and said transfected lymphocyte is activated with an anti-CD3 antibody or a mitogen.